Tuesday, January 23, 2018 - 11:00am to Wednesday, January 24, 2018 - 11:59am
Objective
Following the very successful first virtual NISS-Merck meet-up on the FDA draft guidance on “Multiple Endpoints in Clinical Trials” on September 12, 2017 (recordings available here), the second NISS-Merck meetup held on January 23, 2018 (Tuesday) between 11:00 and 12:00 noon Eastern Daylight Time (EDT) focused on ICH E9(R1): Estimands and Sensitivity Analysis in Clinical Trials. E9(R1) is an addendum to ICH E(9) which describes Statistical Principles for Clinical Trials. Both ICH E9 and E9(R1) were prepared under the auspices of the International Council for Harmonisation. E9(R1) could be located here.
Watch the recording of the NISS-Merck Virtual Meet-up, January 23, 2018
The agenda for the second meet-up:
11:00 - 11:05: Opening the meeting, describing the logistics (Dan Holder, Merck)
11:05 – 11:25: Giving a short summary of decades of research on missing data (Craig Mallinckrodt, Eli Lilly)
11:25 - 11:40: Sharing recommendations in the National Research Council Report (Rod Little, University of Michigan)
11:40 - 12:00: Offering salient points in E9(R1) and moderating panel discussions (Devan Mehrotra, Merck). Panelists are Craig, Rod and Devan.
Presentations
| Attachment | Size |
|---|---|
 1.Mallinckrodt_history.pdf | 108.7 KB |
| 2.Little_mercknissmeetup.pdf | 117.82 KB |
Event Type
- NISS Hosted
Location
Virtual Meet-up. Event password: NISS2018
Policy
